Navigation Links
New Addition to the Prostate Cancer Roundtable Policy Agenda Addresses Quality-of-Life Endpoints

WASHINGTON, Dec. 18, 2013 /PRNewswire/ -- The Prostate Cancer Roundtable has updated its shared national policy agenda for 2014 to include a new policy priority, based on the idea that Phase III clinical trials of new drugs and other forms of treatment that are being tested for their ability to extend overall or progression-free survival should, at the same time, be evaluated for their impact on at least one patient-reported outcome that affects quality of life—at least as a secondary endpoint. For example, does treatment with this drug delay onset of bone pain in men with disseminated prostate cancer?

On Monday, December 9, those attending the Prostate Cancer Roundtable meeting voted unanimously to approve the suggested language and add a new section to the Policy Agenda to read:

"We seek and encourage the inclusion of quality-of-life-related endpoints, based on patient-reported outcomes data, in pivotal trials of all biologic and pharmaceutical agents being assessed for regulatory approval in the treatment of prostate cancer with a primary endpoint of improved survival—such that quality-of-life-related data (positive or negative) as well as survival data can be included in labeling for products indicated for treatment of prostate cancer as and when appropriate."

This revised policy agenda can be found at and serves as the group's policy priorities in discussions with legislators, media and advocates over the next year. The twelve organizations of the Prostate Cancer Roundtable represent the national organizations leading the fight against prostate cancer and speaking on behalf of the hundreds of thousands of patients diagnosed with prostate cancer each year and the estimated 2.2 million men and their families living today who have been diagnosed with the disease.

"While we appreciate the heroic and essential efforts of drug developers, the FDA, and the clinical research community to improve overall patient survival, we also believe that it is critical to patients and families that we study whether life-extending new treatments also have impact on quality of life," said Thomas Kirk, CEO, Us TOO International.

"We're hoping that our inclusion of quality-of-life endpoints as part of our policy agenda will resonate with those stakeholders directly involved with providing prostate cancer care," said Tom Farrington, Founder and President, Prostate Health Education Network. "This is an ambitious but worthy goal which will result in better care for those who not only want their lives extended but also desire a life as close to possible as before the disease."

"Life extension is valuable for patients and the prostate cancer community as a whole," said Wendy Poage, President, Prostate Conditions Education Council. "But being able to also enjoy life, without extensive side effects from treatments and without painful symptoms from their cancer is in many cases, just as important for cancer patients. By including quality of life measures in clinical trials, we will not only better understand the impact of new treatments on patients, but this new policy agenda may also help draw attention to patient-centered concerns and provide better cancer care."

About the Prostate Cancer Roundtable:
The Prostate Cancer Roundtable, representing America's prostate cancer community, is a group of independent, patient-centric, not-for-profit organizations that cooperate to foster the development of policies supporting high quality prostate cancer research, the prevention and early detection of clinically significant prostate cancer, the appropriate care and effective treatment of men with prostate cancer, and the appropriate education of all men at risk for this disease.

The members of the Prostate Cancer Roundtable are:
- Ed Randall's Fans for the Cure (
- Malecare Prostate Cancer Support (
- Men's Health Network (
- National Alliance of State Prostate Cancer Coalitions (
- Prostate Cancer International (
- Prostate Conditions Education Council (
- Prostate Health Education Network (
- The Prostate Net (
- Us TOO International Prostate Cancer Education and Support Network (
- Women Against Prostate Cancer (
- ZERO - The End of Prostate Cancer (

This press release was issued through For further information, visit

SOURCE Prostate Cancer Roundtable
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ACell Nearly Doubles Board of Directors with Addition of Three Members
2. Cyberonics Announces Expansion of Share Repurchase Program By An Additional One Million Shares
3. Roche receives FDA clearance to use additional specimen types for chlamydia and gonorrhea test
4. RXi Pharmaceuticals Announces mRNA Data of an Additional Cohort in the Second Phase 1 Multi-Dose Study with RXI-109, Extending the Dose Response Following Treatment in the Initial 2-week Period
5. Bruin Biometrics Formalizes Management Structure with Appointment of Jeff Greiner and Eve Kurtin to Board of Directors, Plus Additional Executive Leadership
6. Actinium Pharmaceuticals Announces Additional Clinical Data From Multicenter Phase 1/2 Trial on Actiniums Actimab-A to Be Presented at American Society of Hematology Annual Meeting
7. Argos Therapeutics Announces Additional $17.5 Million Of Series E Financing Bringing Total Commitment To $60 Million
8. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 6 Million Shares of Stock through Calendar Year 2014
9. Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Initial Public Offering of Common Stock
10. Middle Peak Medical Raises an Additional $3M to Develop Novel Mitral Valve Technology
11. Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting
Post Your Comments:
(Date:10/9/2015)... , Oct. 9, 2015  Xavier University,s Center ... with Konica Minolta Medical Imaging (KMMI) on October 12. ... Thinking to help healthcare providers imagine and develop their ... roadmap that they can customize for their practice. ... is the initial procedure, or study, in medical imaging ...
(Date:10/9/2015)... BETHESDA, Maryland , October 9, 2015 ... Pharmaceuticals Inc. (OTCQB: CNBX) has announced its execution of ... Debt & Liabilities Agreement with Cannabics, Inc. a Delaware Corporation, ... the company. --> --> ... internal restructuring of the Company, whereby the Research and ...
(Date:10/9/2015)... MELVILLE, N.Y. , Oct. 9, 2015 ... the world,s largest provider of health care products and ... today reminded its customers that the Henry Schein Disaster ... who experience operational, logistical or financial issues as a ... Carolina . The toll-free number for all ...
Breaking Medicine Technology:
... be showcased at National Health Service EXPOSAN JOSE, Calif., April ... ), a worldwide leader in medical devices for the minimally ... today announced that the UK NHS National Innovation Centre has ... a select innovative technology that is bringing benefits to National ...
... MITI ), a biopharmaceutical company developing novel, ... autoimmune diseases, today announced the filing of the first ... Nycomed for the anti-GM-CSF antibody MT203. Micromet received a ... Nycomed for the achievement of this milestone.Under a 2007 ...
Cached Medicine Technology:
(Date:10/9/2015)... , ... October 09, 2015 , ... A new health ... Exam Aid, is now available online ( ) – just in time for ... says officially begins in October. However, for many in the U.S., the real start ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... audiologists in The Tennessean's eighth annual Toast of Music City, a reader’s choice ... Nashville residents nominated and cast votes for their favorite businesses in over 200 ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... company, has announced the final product specifications for TRACTUS, the world’s first sterile ... in the United States in response to the FDA’s recent Unique Device Identifier ...
(Date:10/9/2015)... Stockton, CA (PRWEB) , ... October 09, 2015 ... ... year anniversary of their “Agents of Change” program, a community improvement initiative that ... The newest charity to benefit from the assistance of Confidence Plus Insurance is ...
(Date:10/9/2015)... ... 09, 2015 , ... Prescription Hope, the fastest growing pharmacy ... to save money on the high cost of their prescription medications through their ... and families can receive their medications delivered direct from over 180 U.S.-based pharmaceutical ...
Breaking Medicine News(10 mins):
... concern over skin cancer many people still disregard the use of ... was noticed that one in three Briton do not protect ... cases of skin cancer are diagnosed in the UK each year, ... will treble in the next 30 years. ,Research ...
... born in the United States -- more than double the ... for at least 21 serious disorders, according to the ... ,Massachusetts has failed to make progress on expanding the newborn ... District of Columbia require screening for the 29 core, treatable, ...
... shockingly thin during her performance at Hiro Ballroom on July ... about her emaciated appearance. ,The former Hole singer ... shake, then apologized to the crowd, saying that she "had ... Ensure shakes for my anorexia. You're going to have to ...
... make her sex scenes look realistic has landed her with ... recently admitted that she got into a painful problem while ... Steve Buscemi. ,The 25-year-old actress suffered head injuries ... ,"We were making out and I whacked my head really ...
... In a new study, UCLA researchers measured the effect of ... the physical symptoms of the disease and created ... may help clinicians guide treatment. The study appears in the ... revealed that to effectively treat hepatitis B patients, clinicians need ...
... overall cost-effectiveness of Medicare benefits have been much-debated, new ... receiving benefits at age 65 required more intensive ... insured prior to receiving Medicare. These findings, from researchers ... 12 issue of the New England Journal of Medicine. ...
Cached Medicine News:
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to ...
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to ...
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
Medicine Products: